Staff

Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas

Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas PARIS AND...

Fulcrum Therapeutics Presents Published Structure of Investigational Small Molecule FTX-6058 at the American Chemical Society (ACS) Spring 2021 Virtual Conference

Company initiates dosing in Phase 1 healthy volunteer multiple ascending dose (MAD) cohortCAMBRIDGE, Mass., April 09, 2021 (GLOBE NEWSWIRE) -- Fulcrum...

error: Content is protected !!